Characteristics of non-erosive gastroesophageal reflux disease refractory to proton pump inhibitor therapy

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 14

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

390

HTML

3133

Figures (1-5)

241

Tables (1-2)

204

Sum=3968

Apr 14, 2011 (publication date) through Dec 11, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Apr 14, 2011; 17(14): 1858-1865
Published online Apr 14, 2011. doi: 10.3748/wjg.v17.i14.1858

Full Size Figure Download Figure

Figure 2 Number of reflux episodes of gastric contents to the esophagus with five different treatment regimens on day 14. RPZ: Rabeprazole.

Citation: Sugimoto M, Nishino M, Kodaira C, Yamade M, Uotani T, Ikuma M, Umemura K, Furuta T. Characteristics of non-erosive gastroesophageal reflux disease refractory to proton pump inhibitor therapy. World J Gastroenterol 2011; 17(14): 1858-1865
URL: https://www.wjgnet.com/1007-9327/full/v17/i14/1858.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i14.1858